AGC Biologics adds capacity in Longmont plant, Boulder expansion plans grow

LONGMONT — AGC Biologics Inc. recently completed a roughly 30,000-square-foot expansion project at its Longmont plant, adding cell and gene therapy manufacturing capacity at the sprawling 4000 Nelson Road facility. 

The expansion project at AGC Longmont, which provides contract pharmaceutical manufacturing for drug developers, began last May and cost an estimated $30 million, according to BizWest reporting from that time. 

“Now, AGC Biologics Longmont can offer end-to-end cell therapy development and manufacturing services in one location,” AGC said in a news release Wednesday. “The new labs extend the capabilities at the site and complement the site’s robust viral vector development…